ACADIAN ASSET MANAGEMENT LLC - DIPEXIUM PHARMACEUTICALS INC ownership

DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 19 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of DIPEXIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$3,0000.0%2,0810.0%0.00%
Q4 2016$3,0002,0810.00%
Other shareholders
DIPEXIUM PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Park West Asset Management LLC 194,340$253,0000.02%
MIDDLETON & CO INC/MA 15,848$21,0000.01%
Acrospire Investment Management LLC 4,220$5,0000.00%
Tower Research Capital LLC (TRC) 19,942$26,0000.00%
A.R.T. Advisors, LLC 32,426$42,0000.00%
FNY Partners Fund LP 500$5,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 43,447$56,0000.00%
Raymond James Financial Services Advisors, Inc. 13,200$17,0000.00%
GOLDMAN SACHS GROUP INC 24,378$32,0000.00%
MORGAN STANLEY 7,566$10,0000.00%
View complete list of DIPEXIUM PHARMACEUTICALS INC shareholders